Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Jul;60(7):2769–2776. doi: 10.1128/iai.60.7.2769-2776.1992

Legionella pneumophila lipopolysaccharide activates the classical complement pathway.

C S Mintz 1, D R Schultz 1, P I Arnold 1, W Johnson 1
PMCID: PMC257233  PMID: 1612744

Abstract

Legionella pneumophila is a gram-negative bacterium capable of entering and growing in alveolar macrophages and monocytes. Complement and complement receptors are important in the uptake of L. pneumophila by human mononuclear phagocytes. The surface molecules of L. pneumophila that activate the complement system are unknown. To identify these factors, we investigated the effects of L. pneumophila lipopolysaccharide (LPS) on the classical and alternative complement pathways of normal human serum by functional hemolytic assays. Although incubation of LPS in normal human serum at 37 degrees C resulted in the activation of both pathways, complement activation proceeded primarily through the classical pathway. Activation of the classical pathway by LPS was dependent on natural antibodies of the immunoglobulin M class that were present in various quantities in sera from different normal individuals but were absent in an immunoglobulin-deficient serum obtained from an agammaglobulinemic patient. Additional studies using sheep erythrocytes coated with LPS suggested that the antibodies recognized antigenic sites in the carbohydrate portion of LPS. The ability of LPS to interact with the complement system suggests a role for LPS in the uptake of L. pneumophila by mononuclear phagocytes.

Full text

PDF
2769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avrameas S., Ternynck T. The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry. 1969 Jan;6(1):53–66. doi: 10.1016/0019-2791(69)90178-5. [DOI] [PubMed] [Google Scholar]
  2. Bellinger-Kawahara C., Horwitz M. A. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J Exp Med. 1990 Oct 1;172(4):1201–1210. doi: 10.1084/jem.172.4.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ehret W., Ruckdeschel G. Membrane proteins of legionellaceae. I. Membrane proteins of different strains and serogroups of Legionella pneumophila. Zentralbl Bakteriol Mikrobiol Hyg A. 1985 Jul;259(4):433–445. doi: 10.1016/s0176-6724(85)80075-4. [DOI] [PubMed] [Google Scholar]
  4. Engels W., Endert J., Kamps M. A., van Boven C. P. Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa. Infect Immun. 1985 Jul;49(1):182–189. doi: 10.1128/iai.49.1.182-189.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Forsgren A., Mclean R. H., Michael A. F., Quie P. G. Studies of the alternate pathway in chelated serum. J Lab Clin Med. 1975 Jun;85(6):904–912. [PubMed] [Google Scholar]
  6. Helms C. M., Viner J. P., Sturm R. H., Renner E. D., Johnson W. Comparative features of pneumococcal, mycoplasmal, and Legionnaires' disease pneumonias. Ann Intern Med. 1979 Apr;90(4):543–547. doi: 10.7326/0003-4819-90-4-543. [DOI] [PubMed] [Google Scholar]
  7. Hoffmann E. M., Houle J. J. Failure of Brucella abortus lipopolysaccharide (LPS) to activate the alternative pathway of complement. Vet Immunol Immunopathol. 1983 Nov;5(1):65–76. doi: 10.1016/0165-2427(83)90032-6. [DOI] [PubMed] [Google Scholar]
  8. Horwitz M. A., Silverstein S. C. Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med. 1981 Feb 1;153(2):386–397. doi: 10.1084/jem.153.2.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Horwitz M. A., Silverstein S. C. Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication. J Exp Med. 1981 Feb 1;153(2):398–406. doi: 10.1084/jem.153.2.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Horwitz M. A., Silverstein S. C. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest. 1980 Sep;66(3):441–450. doi: 10.1172/JCI109874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Horwitz M. A. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med. 1983 Dec 1;158(6):2108–2126. doi: 10.1084/jem.158.6.2108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Joiner K. A., Goldman R., Schmetz M., Berger M., Hammer C. H., Frank M. M., Leive L. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4. J Immunol. 1984 Jan;132(1):369–375. [PubMed] [Google Scholar]
  13. King C. H., Fields B. S., Shotts E. B., Jr, White E. H. Effects of cytochalasin D and methylamine on intracellular growth of Legionella pneumophila in amoebae and human monocyte-like cells. Infect Immun. 1991 Mar;59(3):758–763. doi: 10.1128/iai.59.3.758-763.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kohler R. B., Wilde C., 3rd, Johnson W., Joly J., Wheat L. J., Baker R., Misfeldt M. Immunologic diversity among serogroup 1 Legionella pneumophila urinary antigens demonstrated by monoclonal antibody enzyme-linked immunosorbent assays. J Clin Microbiol. 1988 Oct;26(10):2059–2063. doi: 10.1128/jcm.26.10.2059-2063.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Liang-Takasaki C. J., Grossman N., Leive L. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. J Immunol. 1983 Apr;130(4):1867–1870. [PubMed] [Google Scholar]
  16. Loos M., Bitter-Suermann D., Dierich M. Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A. J Immunol. 1974 Mar;112(3):935–940. [PubMed] [Google Scholar]
  17. Otten S., Iyer S., Johnson W., Montgomery R. Serospecific antigens of Legionella pneumophila. J Bacteriol. 1986 Sep;167(3):893–904. doi: 10.1128/jb.167.3.893-904.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Payne N. R., Horwitz M. A. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med. 1987 Nov 1;166(5):1377–1389. doi: 10.1084/jem.166.5.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schiller N. L., Hatch R. A., Joiner K. A. Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect Immun. 1989 Jun;57(6):1707–1713. doi: 10.1128/iai.57.6.1707-1713.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schultz D. R., Arnold P. I. Effect of sequential glycolysis of the lectin of Euonymus europaeus on activation of the classical complement pathway in normal human serum. Mol Immunol. 1982 Dec;19(12):1681–1689. doi: 10.1016/0161-5890(82)90280-2. [DOI] [PubMed] [Google Scholar]
  21. Schultz D. R., Loos M., Bub F., Arnold P. I. Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharide. J Immunol. 1980 Mar;124(3):1251–1257. [PubMed] [Google Scholar]
  22. Sonesson A., Jantzen E., Bryn K., Larsson L., Eng J. Chemical composition of a lipopolysaccharide from Legionella pneumophila. Arch Microbiol. 1989;153(1):72–78. doi: 10.1007/BF00277544. [DOI] [PubMed] [Google Scholar]
  23. Summersgill J. T., Raff M. J., Miller R. D. Interactions of virulent and avirulent Legionella pneumophila with human polymorphonuclear leukocytes. Microb Pathog. 1988 Jul;5(1):41–47. doi: 10.1016/0882-4010(88)90079-4. [DOI] [PubMed] [Google Scholar]
  24. Verbrugh H. A., Lee D. A., Elliott G. R., Keane W. F., Hoidal J. R., Peterson P. K. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway. Immunology. 1985 Apr;54(4):643–653. [PMC free article] [PubMed] [Google Scholar]
  25. Vroon D. H., Schultz D. R., Zarco R. M. The separation of nine components and two inactivators of components of complement in humansserum. Immunochemistry. 1970 Jan;7(1):43–61. doi: 10.1016/0019-2791(70)90029-7. [DOI] [PubMed] [Google Scholar]
  26. Wachter E., Brade V. Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica. Infect Immun. 1989 Jul;57(7):1984–1989. doi: 10.1128/iai.57.7.1984-1989.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Winn W. C., Jr Legionnaires disease: historical perspective. Clin Microbiol Rev. 1988 Jan;1(1):60–81. doi: 10.1128/cmr.1.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wright S. D., Jong M. T. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med. 1986 Dec 1;164(6):1876–1888. doi: 10.1084/jem.164.6.1876. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES